Bacterial infection Clinical Trials

46 recruitingLast updated: May 13, 2026

There are 46 actively recruiting bacterial infection clinical trials across 41 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3. Top locations include Barcelona, Spain, Detroit, Michigan, United States, Bangkok, Thailand. Updated daily from ClinicalTrials.gov.


Bacterial infection Trials at a Glance

46 actively recruiting trials for bacterial infection are listed on ClinicalTrialsFinder across 6 cities in 41 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Barcelona, Detroit, and Bangkok. Lead sponsors running bacterial infection studies include GramEye, Pfizer, and Rambam Health Care Campus.

Browse bacterial infection trials by phase

Treatments under study

About Bacterial infection Clinical Trials

Looking for clinical trials for Bacterial infection? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bacterial infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bacterial infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 46 trials

Recruiting

Emergency PWAS in Respiratory Infectious Disease

Viral infectionsSepsisPneumonia+5 more
The University of Hong Kong2,000 enrolled1 locationNCT05336851
Recruiting
Phase 2

A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)

Gram-negative Bacterial Infection
Pfizer48 enrolled29 locationsNCT06462235
Recruiting
Phase 4

Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)

Bacterial infection
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled10 locationsNCT06709521
Recruiting

Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis

Bacterial InfectionsMeningitisViral Meningitis+1 more
Hospital Israelita Albert Einstein600 enrolled1 locationNCT07062445
Recruiting
Phase 2

Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections

Gram-Negative Bacterial Infections
Pfizer48 enrolled24 locationsNCT05639647
Recruiting
Phase 3

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Non-Hodgkin LymphomaBacterial InfectionsHypogammaglobulinemia+2 more
Grifols Therapeutics LLC386 enrolled62 locationsNCT05645107
Recruiting

Febrile Infants Swedish Study

Serious Bacterial InfectionSepsisBacteremia+4 more
Region Skane2,000 enrolled11 locationsNCT07134751
Recruiting
Not Applicable

Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.

Patient ParticipationBacterial InfectionsInfective Endocarditis+1 more
Region Halland50 enrolled1 locationNCT06704048
Recruiting
Not Applicable

Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections in Pediatrics

Severe Bacterial Infections
Nantes University Hospital1,401 enrolled6 locationsNCT07111793
Recruiting

Changes Associated With H. Pylori and Gastric Carcinogenesis

Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Weill Medical College of Cornell University120 enrolled1 locationNCT02164409
Recruiting

CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit

severe infectionHospitalized ChildrenInvasive Bacterial Infection
Association Clinique Thérapeutique Infantile du val de Marne3,000 enrolled1 locationNCT06260345
Recruiting
Phase 4

Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea

gastroenteritisDiarrheaBacterial infection
Bausch Health Americas, Inc.54 enrolled5 locationsNCT07285785
Recruiting
Phase 4

Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB

Ceftazidime-avibactamAztreonamGram-negative Bacterial Infection+2 more
Jing Zhou144 enrolled1 locationNCT07478484
Recruiting
Phase 3

A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)

Bacterial InfectionsPneumococcal InfectionsStreptococcal Infections
CanSino Biologics Inc.600 enrolled3 locationsNCT07017777
Recruiting
Phase 2

Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.

PneumoniaRespiratory InfectionAcute Respiratory Distress Syndrome+3 more
Vasomune Therapeutics, Inc.120 enrolled5 locationsNCT05123755
Recruiting
Phase 1

[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects

Bacterial Infections
University of Pennsylvania20 enrolled1 locationNCT04263792
Recruiting
Phase 2Phase 3

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Neonatal SepsisPneumoniaInfections+6 more
Minervax ApS338 enrolled6 locationsNCT06592586
Recruiting
Not Applicable

Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract

Viral InfectionMicrobial ColonizationOral Bacterial Infection+1 more
University of California, Irvine200 enrolled1 locationNCT05603650
Recruiting
Phase 1

A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment

Bacterial Infections
Qpex Biopharma, Inc.40 enrolled2 locationsNCT07104162
Recruiting
Phase 2

PMT for MDRO Decolonization

Enterobacteriaceae InfectionsMultidrug Resistant Bacterial Infection
University of Pennsylvania150 enrolled3 locationsNCT05632315